STOCK TITAN

Johnson & Johnson SEC Filings

JNJ NYSE

Welcome to our dedicated page for Johnson & Johnson SEC filings (Ticker: JNJ), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Johnson & Johnson’s vast reach—spanning immunology breakthroughs, orthopedic implants, and everyday consumer staples—makes its SEC disclosures a gold mine of insight and a maze of technical detail. Drug-trial readouts, device recall costs, talc litigation updates, and dividend policy changes are scattered across hundreds of pages, prompting searches like “Johnson & Johnson SEC filings explained simply” and “Johnson & Johnson insider trading Form 4 transactions.”

Stock Titan’s AI decodes every document the moment it hits EDGAR. Whether you need the Johnson & Johnson quarterly earnings report 10-Q filing for segment revenue trends, a Johnson & Johnson annual report 10-K simplified view of risk factors, or a quick alert on Johnson & Johnson Form 4 insider transactions real-time, our platform extracts what matters. Key forms are mapped to practical insights:

  • 10-K & 10-Q: pipeline progress, consumer health margins, R&D spend—ready for instant Johnson & Johnson earnings report filing analysis
  • 8-K: product recalls and courtroom milestones with Johnson & Johnson 8-K material events explained
  • Form 4: track Johnson & Johnson executive stock transactions Form 4 before market moves
  • DEF 14A: explore Johnson & Johnson proxy statement executive compensation alongside peer benchmarks

Busy analysts, portfolio managers, and healthcare specialists use our AI summaries to cut reading time, monitor compliance events, and compare quarter-over-quarter performance. By understanding Johnson & Johnson SEC documents with AI, you can spot safety signals, verify dividend coverage, and gauge insider confidence—without sifting through 300-page PDFs. Real-time feeds, historical archives, and plain-language explanations ensure you never miss a disclosure that could shift your investment thesis.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Filing
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.09%
Tags
other
-
Rhea-AI Summary
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.19%
Tags
current report
Rhea-AI Summary
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.33%
Tags
insider

FAQ

What is the current stock price of Johnson & Johnson (JNJ)?

The current stock price of Johnson & Johnson (JNJ) is $163.7 as of July 18, 2025.

What is the market cap of Johnson & Johnson (JNJ)?

The market cap of Johnson & Johnson (JNJ) is approximately 379.4B.

What are the main business segments of Johnson & Johnson?

Johnson & Johnson operates in pharmaceuticals, medical devices, and consumer health products, addressing a broad spectrum of healthcare needs globally.

How has Johnson & Johnson maintained its competitive edge for over a century?

The company has sustained its leadership through continuous innovation, significant investments in research and development, strategic acquisitions, and strict adherence to quality and ethical standards.

What role does research and development play at Johnson & Johnson?

R&D is central to JNJ’s strategy, driving innovations in therapeutics, diagnostics, and consumer health that help bring breakthrough treatments to market and address unmet medical needs.

How does Johnson & Johnson support its E-E-A-T credentials?

Through decades of proven expertise, a commitment to high quality and safe products, transparent practices, and global regulatory compliance, reinforcing its trustworthiness and authoritativeness.

In what way does Johnson & Johnson impact global healthcare?

By offering a diverse range of products that cater to essential health needs worldwide, strengthening its presence in different markets, and contributing to improved health outcomes.

Why is Johnson & Johnson considered a reliable investment option?

Its diversified business model, long-standing market presence, robust research capabilities, and commitment to ethical practices provide a stable foundation that appeals to investors seeking resilience and growth in the healthcare sector.
Johnson & Johnson

NYSE:JNJ

JNJ Rankings

JNJ Stock Data

379.41B
2.40B
0.06%
73.56%
0.96%
Drug Manufacturers - General
Pharmaceutical Preparations
Link
United States
NEW BRUNSWICK